Christopher Paul Fox
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 111
- Genetics 74
- Chronic Lymphocytic Leukemia Research 54
- Glioma Diagnosis and Treatment 18
- Co-authors
- Kate Cwynarski (21 shared papers)Walter J. F. M. van der Velden (1 shared paper)Per Ljungman (1 shared paper)Dan Engelhard (1 shared paper)Catherine Cordonnier (1 shared paper)Jan Styczyński (1 shared paper)Rafael de la Cámara (1 shared paper)Martin Rowe (5 shared papers)
- Journals
- British Journal of Haematology (30 papers)Blood (27 papers)Hematological Oncology (16 papers)Bone Marrow Transplantation (10 papers)HemaSphere (8 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Christopher Paul Fox
183 papers receiving 6.3k citations
Christopher Paul Fox's Hit Papers
Peers
Comparison fields: 5 of 108
- Genetics 2.0k
- Pathology and Forensic Medicine 3.1k
- Neurology 1.8k
- Oncology 2.0k
- Hematology 579
Countries citing papers authored by Christopher Paul Fox
This map shows the geographic impact of Christopher Paul Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Paul Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Paul Fox more than expected).
Fields of papers citing papers by Christopher Paul Fox
This network shows the impact of papers produced by Christopher Paul Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Paul Fox. The network helps show where Christopher Paul Fox may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Paul Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 199 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial Hit paper breakdown → | 2018 | 554 |
| 2 | Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial Hit paper breakdown → | 2016 | 483 |
| 3 | 2016 | 296 | |
| 4 | 2017 | 291 | |
| 5 | 2019 | 223 | |
| 6 | 2015 | 159 | |
| 7 | 2017 | 157 | |
| 8 | 2013 | 148 | |
| 9 | 2015 | 147 | |
| 10 | 2018 | 118 | |
| 11 | 2022 | 116 | |
| 12 | 2018 | 111 | |
| 13 | 2021 | 111 | |
| 14 | Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease Hit paper breakdown → | 2023 | 109 |
| 15 | 2020 | 99 | |
| 16 | 2020 | 96 | |
| 17 | Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial Hit paper breakdown → | 2024 | 88 |
| 18 | 2020 | 78 | |
| 19 | 2021 | 78 | |
| 20 | 2023 | 76 |
About Christopher Paul Fox
Christopher Paul Fox is a scholar working on Pathology and Forensic Medicine, Genetics, Neurology, Oncology and Immunology, having authored 199 papers that have together received 6.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (111 papers), CNS Lymphoma Diagnosis and Treatment (54 papers), Chronic Lymphocytic Leukemia Research (54 papers), Viral-associated cancers and disorders (35 papers), CAR-T cell therapy research (23 papers), Glioma Diagnosis and Treatment (18 papers), Acute Lymphoblastic Leukemia research (16 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). The work is most often cited by research in Genetics (2.0k citations), Pathology and Forensic Medicine (3.1k citations), Neurology (1.8k citations), Oncology (2.0k citations) and Hematology (579 citations). Christopher Paul Fox has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Kate Cwynarski, Walter J. F. M. van der Velden, Per Ljungman, Dan Engelhard, Catherine Cordonnier, Jan Styczyński, Rafael de la Cámara, Martin Rowe, Toby Andrew Eyre and Elizabeth H. Phillips. Their work appears in journals such as British Journal of Haematology, Blood, Hematological Oncology, Bone Marrow Transplantation and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.